Arbutus Biopharma Corporation ABUS Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Arbutus Biopharma Corporation’s reported figures.
The official record: Arbutus Biopharma Corporation’s 10-K, filed March 23, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arbutus Biopharma Corporation's free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arbutus Biopharma Corporation's free cash flow?
- Arbutus Biopharma Corporation (ABUS) reported free cash flow of -$4.68M in Q4 2025.
- How has Arbutus Biopharma Corporation's free cash flow changed year-over-year?
- Arbutus Biopharma Corporation's free cash flow increased by 55.0% year-over-year, from -$10.4M to -$4.68M.
- What is the long-term trend for Arbutus Biopharma Corporation's free cash flow?
- Over 4 years (2021 to 2025), Arbutus Biopharma Corporation's free cash flow has grown at a -12.7% compound annual growth rate (CAGR), from -$68.34M to -$39.64M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.